A 3-day-old male neonate, born to a 28-year-old primigravida mother with prolonged rupture of membranes (PROM) for 18 hours, presents with poor feeding, lethargy, and a temperature of 38.2°C (rectal). On examination, the infant appears ill with mild abdominal distension and hepatomegaly. Blood culture is pending. Complete blood count shows WBC 4,200/μL (reference: 5,000–21,000), platelets 85,000/μL, and CRP 24 mg/L. What is the most appropriate initial management?

Explanation

## Neonatal Sepsis: Early-Onset Sepsis (EOS) Management ### Clinical Context This 3-day-old neonate has multiple risk factors for early-onset sepsis (EOS): - Maternal PROM >12 hours (major risk factor for GBS and gram-negative organisms) - Maternal fever/chorioamnionitis (implied by clinical presentation) - Signs of systemic infection: fever, lethargy, poor feeding, hepatomegaly - Laboratory evidence: leukopenia (WBC 4,200), thrombocytopenia, elevated CRP ### Empirical Antibiotic Regimen for EOS **Key Point:** The standard empirical regimen for suspected neonatal sepsis in the first 72 hours is **ampicillin + gentamicin ± acyclovir**. | Antibiotic | Spectrum | Rationale | |---|---|---| | **Ampicillin** | GBS, *Listeria monocytogenes*, susceptible gram-negatives | Essential for GBS (vertical transmission) | | **Gentamicin** | Gram-negative organisms (*E. coli*, *Klebsiella*) | Synergistic with ampicillin for GBS; covers gram-negatives | | **Acyclovir** | HSV-1, HSV-2 | Added if maternal history of genital herpes or vesicular rash | ### Why Ampicillin + Gentamicin? 1. **GBS coverage**: *Streptococcus agalactiae* is the most common cause of EOS in developed countries. Ampicillin is the drug of choice (penicillin G is also acceptable). 2. **Gram-negative coverage**: Gentamicin covers *E. coli* K1 and other enteric organisms, which are common in PROM. 3. **Synergy**: Ampicillin + gentamicin is synergistic against GBS. 4. **Listeria coverage**: Ampicillin (not cephalosporins) covers *Listeria*, which can cause neonatal meningitis. **Clinical Pearl:** Cephalosporins (ceftriaxone, cefotaxime) are **NOT** first-line for EOS because they do not reliably cover *Listeria monocytogenes*. They are reserved for late-onset sepsis (LOS, >72 hours) or meningitis in older neonates. ### Acyclovir Indication Acyclovir is added if there is: - Maternal history of genital herpes simplex virus (HSV) - Maternal primary HSV infection near delivery - Vesicular rash in the neonate - Unexplained sepsis with CSF pleocytosis In this case, no HSV risk is mentioned, but acyclovir may still be considered empirically if maternal history is unknown. **High-Yield:** The mnemonic for neonatal sepsis empirical therapy is **"AGE"**: - **A**mpicillin (for GBS and *Listeria*) - **G**entamicin (for gram-negatives) - **E**ither acyclovir (if HSV risk) or observe ### Timing of Antibiotics **Key Point:** Antibiotics must be started **immediately after blood culture** (not before, to avoid contamination, but without delay). Do not wait for culture results. ### Why Not Ceftriaxone Monotherapy? Ceftriaxone alone is inadequate for EOS because: - Does not cover *Listeria monocytogenes* - Monotherapy is inferior to combination therapy for GBS meningitis - Not standard for age <72 hours ### Why Not Vancomycin + Cefotaxime? This combination is used for **late-onset sepsis (LOS, >72 hours)** or neonatal meningitis in older infants, when *Listeria* risk is lower and resistant organisms are more common. It is not first-line for EOS. ## Summary Algorithm ```mermaid flowchart TD A[Neonatal sepsis suspected]:::outcome --> B{Age at onset?}:::decision B -->|< 72 hours: EOS| C[Ampicillin + Gentamicin]:::action B -->|≥ 72 hours: LOS| D[Vancomycin + Cefotaxime]:::action C --> E{HSV risk?}:::decision E -->|Yes| F[Add Acyclovir]:::action E -->|No| G[Start therapy after blood culture]:::action D --> H[Start therapy after blood culture]:::action ```